Novo Nordisk’s obesity drug cuts risk of strokes and heart attacks
Shares in Danish drugmaker and US rival Eli Lilly surge to record highs after positive trial of weight-loss drug #press
https://www.ft.com/content/b8617703-2608-4d2e-8d39-6d4ab1176ffd?utm_source=press.coop